Breast cancer typically has a high level of heterogeneity and can be further categorized into multiple subtypes with respect to various molecular and pathological signatures, including Her2 status, estrogen receptor (ER) status, progesterone receptor (PR) status, and PAM50 features [2, 3]. This evidence concerns the gene ESR1 and breast cancer.